Bolak Co

Bolak Co Net Margin

The Net Profit Margin of Bolak Co (002760.KS) as of Oct 28, 2026 is 4.67 %. In the previous year, Net Profit Margin was -3.17 % — a change of -247.19% (higher).

Net Margin

4.67 %

YoY

-247.19%

Last updated:

Net Profit Margin of Bolak Co is 2025 4.67 % . Net Profit Margin of Bolak Co was 2024 -3.17 % . It decreases by -247.19% higher compared to the previous year.

Bolak Co's net margin stands at 4.7%, broadly stable from 4.3% several years earlier.

The Bolak Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
3.27 KRW
Jan 1, 2019
1.80 KRW
Jan 1, 2020
1.03 KRW
Jan 1, 2021
4.26 KRW
Jan 1, 2022
6.34 KRW
Jan 1, 2023
1.83 KRW
Jan 1, 2024
-3.17 KRW
Jan 1, 2025
4.67 KRW
The Bolak Co Net Margin history
YEARNet MarginYoY
4.67 %-247.19%
-3.17 %-272.94%
1.83 %-71.06%
6.34 %+48.65%
4.26 %+313.75%
1.03 %-42.61%
1.80 %-45.15%
3.27 %-11.60%
3.70 %-56.40%
8.49 %-1,629.80%
-0.56 %-108.32%
6.68 %+28,412.43%
0.02 %-61.72%
0.06 %+1,136.97%
0.00-86.43%
0.04 %+69.13%
0.02 %+107.23%
0.01 %-112.62%
-0.08 %-267.14%
0.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bolak Co Stock analysis

What does Bolak Co do? Bolak Co., Ltd. generates revenue through its two core business divisions: food additives and pharmaceutical ingredients. The food additives division produces flavors, colors, botanical extracts, nutraceuticals, white emulsion, antioxidants, emulsifiers, bleaching agents, acidulant, and sweetness products. The pharmaceutical ingredients division manufactures extract powers, fluid extracts, tinctures, protein concentrates, and calcium carboxymethyl cellulose (CMC). Domestic and overseas markets purchase these products, with the company distributing them across both regions. The firm's product portfolio targets food manufacturers and pharmaceutical companies seeking raw materials for their production processes. Bolak Co., Ltd. serves food manufacturers and pharmaceutical companies as its primary customer segments. These segments require specialized ingredients for their product development and production lines. The company's domestic market includes Korean food and pharma firms, while overseas buyers include international food processors and pharmaceutical producers. The firm's product range supports both the food and pharmaceutical industries through direct sales to these end-users. The company's revenue streams are derived from the sale of its manufactured ingredients, with no mention of additional services or licensing. Food additives like white emulsion and antioxidants are sold to food producers, while pharmaceutical ingredients such as protein concentrates and CMC are supplied to drug manufacturers. The business model relies on consistent demand for these raw materials from established industry clients. Bolak Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bolak Co stock

Net Profit Margin of Bolak Co is 4.67 % in 2025.

Net Profit Margin of Bolak Co changed from -3.17 % to 4.67 %, representing a -247.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Bolak Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Bolak Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bolak Co

All Key Metrics — Bolak Co